These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35362242)

  • 1. Emotion regulation and social knowledge in youth at clinical high-risk for psychosis and outpatients with chronic schizophrenia: Associations with functional outcome and negative symptoms.
    Macfie WG; Spilka MJ; Bartolomeo LA; Gonzalez CM; Strauss GP
    Early Interv Psychiatry; 2023 Jan; 17(1):21-28. PubMed ID: 35362242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defeatist performance beliefs in individuals at clinical high-risk for psychosis and outpatients with chronic schizophrenia.
    Clay KB; Raugh IM; Bartolomeo LA; Strauss GP
    Early Interv Psychiatry; 2021 Aug; 15(4):865-873. PubMed ID: 32743974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premorbid adjustment in childhood is associated with later emotion management in first-episode schizophrenia.
    Bridgwater MA; Horton LE; Haas GL
    Schizophr Res; 2022 Feb; 240():233-238. PubMed ID: 35093858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated emotion reactivity and emotion regulation in individuals at clinical high risk for developing psychosis and those diagnosed with a psychotic disorder.
    Vines L; Bridgwater M; Bachman P; Hayes R; Catalano S; Jalbrzikowski M
    Early Interv Psychiatry; 2022 Jul; 16(7):724-735. PubMed ID: 34528404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emotional intelligence in schizophrenia.
    Kee KS; Horan WP; Salovey P; Kern RS; Sergi MJ; Fiske AP; Lee J; Subotnik KL; Nuechterlein K; Sugar CA; Green MF
    Schizophr Res; 2009 Jan; 107(1):61-8. PubMed ID: 18805674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for Psychosis.
    Modinos G; Kempton MJ; Tognin S; Calem M; Porffy L; Antoniades M; Mason A; Azis M; Allen P; Nelson B; McGorry P; Pantelis C; Riecher-Rössler A; Borgwardt S; Bressan R; Barrantes-Vidal N; Krebs MO; Nordentoft M; Glenthøj B; Ruhrmann S; Sachs G; Rutten B; van Os J; de Haan L; Velthorst E; van der Gaag M; Valmaggia LR; McGuire P;
    JAMA Psychiatry; 2020 Feb; 77(2):190-200. PubMed ID: 31722018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurophysiological Correlate of Emotion Regulation by Cognitive Reappraisal and Its Association With Psychotic Symptoms in Early Psychosis.
    Kim M; Hwang WJ; Park J; Kim T; Oh S; Kwon JS
    Schizophr Bull; 2021 Jan; 47(1):87-96. PubMed ID: 32609340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental factors contributing to negative symptoms in youth at clinical high risk for psychosis and outpatients with schizophrenia.
    Strauss GP
    Soc Psychiatry Psychiatr Epidemiol; 2024 Jul; 59(7):1167-1175. PubMed ID: 37624464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of emotion awareness and regulation on social functioning in individuals at clinical high risk for psychosis.
    Kimhy D; Gill KE; Brucato G; Vakhrusheva J; Arndt L; Gross JJ; Girgis RR
    Psychol Med; 2016 Oct; 46(14):2907-2918. PubMed ID: 27050714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological deficits in participants at clinical high risk for psychosis recruited from the community: relationships to functioning and clinical symptoms.
    Haining K; Matrunola C; Mitchell L; Gajwani R; Gross J; Gumley AI; Lawrie SM; Schwannauer M; Schultze-Lutter F; Uhlhaas PJ
    Psychol Med; 2020 Jan; 50(1):77-85. PubMed ID: 30862319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of the COVID-19 pandemic on negative symptoms in individuals at clinical high-risk for psychosis and outpatients with chronic schizophrenia.
    Strauss GP; Macdonald KI; Ruiz I; Raugh IM; Bartolomeo LA; James SH
    Eur Arch Psychiatry Clin Neurosci; 2022 Feb; 272(1):17-27. PubMed ID: 33881621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social cognition in clinical "at risk" for psychosis and first episode psychosis populations.
    Thompson A; Papas A; Bartholomeusz C; Allott K; Amminger GP; Nelson B; Wood S; Yung A
    Schizophr Res; 2012 Nov; 141(2-3):204-9. PubMed ID: 22959742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Social cognition over time in individuals at clinical high risk for psychosis: Findings from the NAPLS-2 cohort.
    Piskulic D; Liu L; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; Addington J
    Schizophr Res; 2016 Mar; 171(1-3):176-81. PubMed ID: 26785807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced willingness to expend effort for rewards is associated with risk for conversion and negative symptom severity in youth at clinical high-risk for psychosis.
    Strauss GP; Bartolomeo LA; Luther L
    Psychol Med; 2023 Feb; 53(3):714-721. PubMed ID: 34120660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anomalous Self-Experiences and positive symptoms are independently associated with emotion processing deficits in schizophrenia.
    Cicero DC; Klaunig MJ; Trask CL; Neis AM
    Schizophr Res; 2016 Oct; 176(2-3):456-461. PubMed ID: 27562615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing social-cognitive deficits in schizophrenia with the Mayer-Salovey-Caruso Emotional Intelligence Test.
    Eack SM; Greeno CG; Pogue-Geile MF; Newhill CE; Hogarty GE; Keshavan MS
    Schizophr Bull; 2010 Mar; 36(2):370-80. PubMed ID: 18648021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emotion regulation across the psychosis continuum.
    Chapman HC; Visser KF; Mittal VA; Gibb BE; Coles ME; Strauss GP
    Dev Psychopathol; 2020 Feb; 32(1):219-227. PubMed ID: 30739633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal stability of social cognition in schizophrenia: A 5-year follow-up of social perception and emotion processing.
    McCleery A; Lee J; Fiske AP; Ghermezi L; Hayata JN; Hellemann GS; Horan WP; Kee KS; Kern RS; Knowlton BJ; Subotnik KL; Ventura J; Sugar CA; Nuechterlein KH; Green MF
    Schizophr Res; 2016 Oct; 176(2-3):467-472. PubMed ID: 27443808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deconstructing emotion regulation in schizophrenia: The nature and consequences of abnormalities in monitoring dynamics.
    Bartolomeo LA; Raugh IM; Strauss GP
    Schizophr Res; 2022 Feb; 240():135-142. PubMed ID: 35026598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beliefs About the Uncontrollability and Usefulness of Emotion in the Schizophrenia-Spectrum: Links to Emotion Regulation and Negative Symptoms.
    Berglund AM; James SH; Raugh IM; Strauss GP
    Cognit Ther Res; 2023; 47(2):282-294. PubMed ID: 36779179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.